Report Summary
Insulin Delivery Devices include syringes, pens, pumps, and others. The cost of syringes and insulin pens is low, which enables users to opt for them as first choice devices. High cost of insulin pumps and insulin jet injectors poses a challenge to the growth of the market. Insulin pumps and jet injectors also require special care and maintenance, which is an additional cost burden to patients.
In 2017, the insulin pens segment accounted for the largest share of the global insulin delivery devices market. The insulin pens segment is further divided into reusable pens and disposable pens.
On the basis of end-user, the patients/homecare segment commanded the largest share of the insulin delivery devices market in 2017, and is expected to grow at the highest CAGR during the forecast period.
In 2017, North America accounted for the largest share of the global insulin delivery devices market. The large share of this segment can be attributed to the rising prevalence of diabetes and favorable reimbursement scenario in the U.S. and Canada, growing venture capital investments and issuance of IPOs in the U.S., and FDA approvals to increase the commercial availability of insulin delivery devices in the U.S.
The global Insulin Delivery Devices market was xx million US$ in 2023 and is expected to xx million US$ by the end of 2034, growing at a CAGR of xx% between 2024 and 2034.
This report studies the Insulin Delivery Devices market size (value and volume) by players, regions, product types and end industries, history data 2019-2022 and forecast data 2024-2034; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Insulin Delivery Devices in these regions, from 2019 to 2034, covering
- North America (United States, Canada and Mexico)
- Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
- Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
- South America (Brazil etc.)
- Middle East and Africa (Egypt and GCC Countries)
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include
- Novo Nordisk
- Sanofi
- BD
- Eli Lilly
- Medtronic
- Animas
- Beta Bionics
- Cellnovo
- Copernicus
- Dance Biopharm
- Debiotech
- Insulet
- MannKind
- Owen Mumford
- Roche
- SOOIL
- Tandem Diabetes Care
- Valeritas
- West Pharma
- Ypsomed
Insulin Delivery Devices Market, By Product
- Pens
- Reusable Pens
- Disposable Pens
- Pumps
- External/Tethered Pumps
- Patch Pumps
- Pen Needles
- Standard Pen Needles
- Safety Pen Needles
- Syringes
- Other Devices
Insulin Delivery Devices Market, By End-use
- Hospitals
- Homecare
- Others
We can also provide customized separate regional or country-level reports, for the following regions:
- North America
- United States
- Canada
- Mexico
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Singapore
- Malaysia
- Philippines
- Thailand
- Vietnam
- Rest of Asia-Pacific
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Russia
- Rest of Europe
- Central & South America
- Brazil
- Rest of Central & South America
- Middle East & Africa
- GCC Countries
- Turkey
- Egypt
- South Africa
- Rest of Middle East & Africa
The study objectives of this report are:
- To study and analyze the global Insulin Delivery Devices market size (value & volume) by company, key regions/countries, products and application, history data from 2019 to 2022, and forecast to 2034.
- To understand the structure of Insulin Delivery Devices market by identifying its various subsegments.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- Focuses on the key global Insulin Delivery Devices manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
- To analyze the Insulin Delivery Devices with respect to individual growth trends, future prospects, and their contribution to the total market.
- To project the value and volume of Insulin Delivery Devices submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Insulin Delivery Devices are as follows:
History Year: 2019-2022
Base Year: 2023
Estimated Year: 2024
Forecast Year 2024 to 2034
This report includes the estimation of market size for value (million USD) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Insulin Delivery Devices market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
- Key Stakeholders
- Raw material suppliers
- Distributors/traders/wholesalers/suppliers
- Regulatory bodies, including government agencies and NGO
- Commercial research & development (R&D) institutions
- Importers and exporters
- Government organizations, research organizations, and consulting firms
- Trade associations and industry bodies
- End-use industries
Available Customizations
With the given market data, EternityInsights offers customizations according to the company's specific needs. The following customization options are available for the report:
Further breakdown of Insulin Delivery Devices market on basis of the key contributing countries. Detailed analysis and profiling of additional market players.
Table Of Contents
Table of Contents
1 Insulin Delivery Devices Market Overview
1.1 Insulin Delivery Devices Product Overview
1.2 Insulin Delivery Devices Market Segment by Type
1.2.1 Insulin Pens
1.2.2 Insulin Pumps
1.2.3 Insulin Syringes
1.2.4 Others
1.3 Global Insulin Delivery Devices Market Size by Type
1.3.1 Global Insulin Delivery Devices Sales and Growth by Type
1.3.2 Global Insulin Delivery Devices Sales and Market Share by Type (2017-2020)
1.3.3 Global Insulin Delivery Devices Revenue and Market Share by Type (2017-2020)
1.3.4 Global Insulin Delivery Devices Price by Type (2017-2020)
2 Global Insulin Delivery Devices Market Competition by Company
2.1 Global Insulin Delivery Devices Sales and Market Share by Company (2017-2020)
2.2 Global Insulin Delivery Devices Revenue and Share by Company (2017-2020)
2.3 Global Insulin Delivery Devices Price by Company (2017-2020)
2.4 Global Top Players Insulin Delivery Devices Manufacturing Base Distribution, Sales Area, Product Types
2.5 Insulin Delivery Devices Market Competitive Situation and Trends
2.5.1 Insulin Delivery Devices Market Concentration Rate
2.5.2 Global Insulin Delivery Devices Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Insulin Delivery Devices Company Profiles and Sales Data
3.1 Novo Nordisk
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Insulin Delivery Devices Product Category, Application and Specification
3.1.3 Novo Nordisk Insulin Delivery Devices Sales, Revenue, Price and Gross Margin(2017-2020)
3.1.4 Main Business Overview
3.2 Sanofi
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Insulin Delivery Devices Product Category, Application and Specification
3.2.3 Sanofi Insulin Delivery Devices Sales, Revenue, Price and Gross Margin(2017-2020)
3.2.4 Main Business Overview
3.3 BD
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Insulin Delivery Devices Product Category, Application and Specification
3.3.3 BD Insulin Delivery Devices Sales, Revenue, Price and Gross Margin(2017-2020)
3.3.4 Main Business Overview
3.4 Eli Lilly
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Insulin Delivery Devices Product Category, Application and Specification
3.4.3 Eli Lilly Insulin Delivery Devices Sales, Revenue, Price and Gross Margin(2017-2020)
3.4.4 Main Business Overview
3.5 Medtronic
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Insulin Delivery Devices Product Category, Application and Specification
3.5.3 Medtronic Insulin Delivery Devices Sales, Revenue, Price and Gross Margin(2017-2020)
3.5.4 Main Business Overview
3.6 Animas
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Insulin Delivery Devices Product Category, Application and Specification
3.6.3 Animas Insulin Delivery Devices Sales, Revenue, Price and Gross Margin(2017-2020)
3.6.4 Main Business Overview
3.7 Beta Bionics
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Insulin Delivery Devices Product Category, Application and Specification
3.7.3 Beta Bionics Insulin Delivery Devices Sales, Revenue, Price and Gross Margin(2017-2020)
3.7.4 Main Business Overview
3.8 Cellnovo
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Insulin Delivery Devices Product Category, Application and Specification
3.8.3 Cellnovo Insulin Delivery Devices Sales, Revenue, Price and Gross Margin(2017-2020)
3.8.4 Main Business Overview
3.9 Copernicus
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Insulin Delivery Devices Product Category, Application and Specification
3.9.3 Copernicus Insulin Delivery Devices Sales, Revenue, Price and Gross Margin(2017-2020)
3.9.4 Main Business Overview
3.10 Dance Biopharm
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Insulin Delivery Devices Product Category, Application and Specification
3.10.3 Dance Biopharm Insulin Delivery Devices Sales, Revenue, Price and Gross Margin(2017-2020)
3.10.4 Main Business Overview
3.11 Debiotech
3.12 Insulet
3.13 MannKind
3.14 Owen Mumford
3.15 Roche
3.16 SOOIL
3.17 Tandem Diabetes Care
3.18 Valeritas
3.19 West Pharma
3.20 Ypsomed
4 Insulin Delivery Devices Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Insulin Delivery Devices Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Insulin Delivery Devices Sales and Revenue by Regions
4.2.1 Global Insulin Delivery Devices Sales and Market Share by Regions (2017-2020)
4.2.2 Global Insulin Delivery Devices Revenue and Market Share by Regions (2017-2020)
4.2.3 Global Insulin Delivery Devices Sales, Revenue, Price and Gross Margin (2017-2020)
4.3 North America Insulin Delivery Devices Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Insulin Delivery Devices Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Insulin Delivery Devices Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Insulin Delivery Devices Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Insulin Delivery Devices Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Insulin Delivery Devices Application/End Users
5.1 Insulin Delivery Devices Segment by Application
5.1.1 Patients/Homecare
5.1.2 Hospitals & Clinics
5.2 Global Insulin Delivery Devices Product Segment by Application
5.2.1 Global Insulin Delivery Devices Sales by Application
5.2.2 Global Insulin Delivery Devices Sales and Market Share by Application (2017-2020)
6 Global Insulin Delivery Devices Market Forecast
6.1 Global Insulin Delivery Devices Sales, Revenue Forecast (2021-2027)
6.1.1 Global Insulin Delivery Devices Sales and Growth Rate Forecast (2021-2027)
6.1.1 Global Insulin Delivery Devices Revenue and Growth Rate Forecast (2021-2027)
6.2 Global Insulin Delivery Devices Forecast by Regions
6.2.1 North America Insulin Delivery Devices Sales and Revenue Forecast (2021-2027)
6.2.2 Europe Insulin Delivery Devices Sales and Revenue Forecast (2021-2027)
6.2.3 Asia-Pacific Insulin Delivery Devices Sales and Revenue Forecast (2021-2027)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Insulin Delivery Devices Sales and Revenue Forecast (2021-2027)
6.2.5 Middle East and Africa Insulin Delivery Devices Sales and Revenue Forecast (2021-2027)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Insulin Delivery Devices Forecast by Type
6.3.1 Global Insulin Delivery Devices Sales and Revenue Forecast by Type (2021-2027)
6.3.2 Insulin Pens Gowth Forecast
6.3.3 Insulin Pumps Gowth Forecast
6.4 Insulin Delivery Devices Forecast by Application
6.4.1 Global Insulin Delivery Devices Sales Forecast by Application (2021-2027)
6.4.2 Global Insulin Delivery Devices Forecast in Patients/Homecare
6.4.3 Global Insulin Delivery Devices Forecast in Hospitals & Clinics
7 Insulin Delivery Devices Upstream Raw Materials
7.1 Insulin Delivery Devices Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Insulin Delivery Devices Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer
